Home Neurodon

Neurodon

In operation
Donation/ Crowdfunding
Pharmaceutical R&D Developer
Basic
Enterprise Profile

Basic Information

Neurodon is developing disease-modifying drugs for neurodegeneration, diabetes, and other life-threatening conditions. Neurodon utilizes its proprietary Endoplasmic Reticulum (ER) stress technology platform to discover small molecules that can reduce cellular dysfunction, which is a root cause of many diseases.
Neurodon
Indiana,United States of America
less than 15 people
April 10, 2012
rdahl@neurodon.net

Enterprise Profile

Industrial Sector
New Drug Development Manufacture of Biological Pharmaceutical Products
Technology
Biotechnology
Concept
Ophthalmology Mental Disorders Therapeutic Products # Diabetes Mellitus
Application Scenarios
Chemical Drug Innovative Drugs Prescription Drug